Should I Buy PBH? PBH 2026 Analysis

Should You Buy Prestige Consumer Healthcare Inc (PBH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

63.900

1 Day change

1.19%

52 Week Range

90.040

Analysis Updated At

2026/01/26

Prestige Consumer Healthcare Inc (PBH) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks clear positive momentum, has declining financial performance, and no significant recent news or catalysts to drive growth. While hedge funds are increasing their positions, the technical indicators and options data do not suggest a compelling entry point. A hold strategy is recommended until stronger growth signals or catalysts emerge.

Technical Analysis

The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 54.617, suggesting no clear overbought or oversold conditions. The stock is trading near its pivot level of 65.556, with support at 63.497 and resistance at 67.615, showing limited immediate upside potential.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

Hedge funds have significantly increased their buying activity, up 622.44% over the last quarter. Analysts maintain a generally positive outlook with several buy ratings and price target increases for related companies.

Neutral/Negative Catalysts

The company's financial performance has declined significantly in Q2 2026, with revenue down 3.41% YoY, net income down 22.37% YoY, and EPS down 21.10% YoY. No recent news or event-driven catalysts have been identified. Insider trading activity is neutral, and there is no recent congress trading data.

Financial Performance

In Q2 2026, Prestige Consumer Healthcare Inc reported a revenue decline of 3.41% YoY to $274.1M, net income dropped 22.37% YoY to $42.2M, and EPS fell 21.10% YoY to 0.86. Gross margin slightly decreased to 53.41%, down 0.17% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment for PBH is mixed. Canaccord lowered the price target from $100 to $88 but maintained a Buy rating, citing solid results despite timing issues. However, no recent upgrades or strong bullish signals for PBH specifically were noted.

4 Analyst Rating

Wall Street analysts forecast PBH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PBH is 77 USD with a low forecast of 71 USD and a high forecast of 88 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

1 Hold

0 Sell

Strong Buy

Current: 63.150

Low

Averages

High

Current: 63.150

Low

Averages

High

Scotiabank

Sector Perform

Outperform

upgrade

$99 -> $120

AI Analysis

2025-12-18

Reason

Scotiabank

Price Target

$99 -> $120

AI Analysis

2025-12-18

upgrade

Sector Perform

Outperform

Reason

Scotiabank upgraded Premium Brands to Outperform from Sector Perform with a price target of C$120, up from C$99. The firm cites merger synergies, expectants for meaningful de-leverage over the next 6-12 months, and the company's exposure to stronger consumer spending growth in the U.S. in 2026 for the upgrade.

TD Securities

NULL -> Buy

maintain

$145 -> $160

2025-12-18

Reason

TD Securities

Price Target

$145 -> $160

2025-12-18

maintain

NULL -> Buy

Reason

TD Securities raised the firm's price target on Premium Brands to C$160 from C$145 and keeps a Buy rating on the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for PBH

Unlock Now

PBH Should I Buy

PBH Should I Buy

Should You Buy Prestige Consumer Healthcare Inc (PBH) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch